Shanghai Henlius Biotech

About:

Shanghai Henlius Biotech is joint venture company that provides clinical-stage biopharmaceutical services.

Website: http://www.henlius.com/en/index.html

Top Investors: CICC, Fosun Pharma, Korea Investment Partners, Loyal Valley Capital, New China Capital Management

Description:

Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services. The company focuses on the development, production and commercialization of mAb biosimilar drugs, bio-betters, and novel mAbs using cutting-edge technology. The company is a joint venture between Shanghai Fosun Pharmaceutical and Henlius Biopharmaceuticals, formed in 2009. It is headquartered in the Shanghai Caohejing High-Technology Park.